TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer. - Karma

Karolinska Mammography Project
for Risk Prediction of Breast Cancer

The KARMA study is supported by the Märit and Hans Rausing Initiative Against Breast Cancer, the Swedish Research Council, the Swedish Cancer Society, the Kamprad Foundation, and Stockholm County Council.

Karolinska Mammography Project
for Risk Prediction of Breast Cancer

The KARMA study is supported by the Märit and Hans Rausing Initiative Against Breast Cancer, the Swedish Research Council, the Swedish Cancer Society, the Kamprad Foundation, and Stockholm County Council.

2017

TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer.

Fagerholm R, Khan S, Schmidt MK, García-Closas M, Heikkilä P, Saarela J, Beesley J, Jamshidi M, et al.

https://pubmed.ncbi.nlm.nih.gov/28179588/